Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Isoflurane: Will receive isoflurane to maintain bis 40-60 and emergence time will be noted
Control Intervention1: Sevoflurane: will receive sevoflurane to maintain bis 40-60 and emergen
Sponsors
PGIMER chandigarh
Eligibility
Inclusion criteria
Inclusion criteria: American Society of Anaesthesiologists physical status I /II/III Middle aged women, 45-65 years Patient willing to participate in the tri
Exclusion criteria
Exclusion criteria: Any contraindication to use of supraglottic airway device Renal dysfunction(Serum creatinine >1.2 mg/dl) Advanced liver disease (liver enzymes twice the normal range or higher) Cardiac dysfunction BMI = 35 H/o of chronic use of sedatives/narcotics.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Awakening timeTimepoint: time from the end of procedure to eye opening in response to voice | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to remove the airway device Time to discharge from PACU (Modified aldrette score 9) Percentage change in hemodynamics during induction and maintenance Incidence of any adverse events. Consumption of inhalation agent. Timepoint: time from the end of procedure to removal of I-gel | — |
Countries
India
Contacts
Public ContactRamya R
PGIMER, chandigarh
Outcome results
None listed